Monitoring lipodystrophy

Body-fat changes can be monitored in a number of ways:

  • Skin-fold tests: this test uses callipers to measure the quantity of subcutaneous fat. It needs to be done by a dietitian or doctor experienced in use of the test, and can be used to monitor changes in the amount of subcutaneous fat on the arms or legs. However, these changes are not representative of total body fat changes.
  • Bioelectrical impedance analysis (BIA): this test passes a small electric current through the body. Since fat is a poor electrical conductor compared to muscle, the body presents an impedance (a more complex measure of electrical resistance) to the current which can be measured and used to determine proportions of overall lean body mass, fat, and other body composition compartments. BIA cannot detect regional changes in body fat, only total body fat changes.
  • Dual energy X-ray absorptiometry (DEXA) scan is a method which can show the distribution of fat, muscle and bone in the body, and can detect changes in different parts of the body. It is likely to produce more accurate measurements of fat loss from the limbs, because it cannot distinguish between subcutaneous and visceral fat. However, this test is expensive, requires elaborate equipment which is not available everywhere, and is less accurate in very thin or very obese people.
  • Computerised tomography (CT) scan: this is a type of X-ray in which the X-ray source and the scanner rotate around the body. It produces detailed cross-sectional images of the body, and is considered the most accurate measure of whole body subcutaneous and visceral fat. Again, this test is expensive and little used outside of research settings.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.